Epizyme Total Current Liabilities 2011-2025 | EPZM

Annual Total Current Liabilities Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.2 M	43.4 M	34.4 M	37.8 M	24.7 M	21.6 M	18.4 M	17 M	34.6 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
45.2 M	17 M	30.8 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	22.5 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	31.6 M	$ 3.29	-2.08 %	$ 254 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Amphastar Pharmaceuticals AMPH	174 M	$ 25.32	-2.24 %	$ 1.23 B	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	72.8 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	54.1 M	-	-	$ 1.01 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	4.34 M	$ 1.31	-1.88 %	$ 7.14 M	China
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Anika Therapeutics ANIK	31.1 M	$ 9.55	0.58 %	$ 140 M	USA
Brickell Biotech BBI	1.66 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	2.21 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	3.77 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	45.5 M	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	1.8 M	$ 12.34	-4.78 %	$ 508 M	USA
Aytu BioScience AYTU	63.1 M	$ 2.35	3.0 %	$ 14.8 M	USA
Arena Pharmaceuticals ARNA	66.3 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	21.5 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
ChromaDex Corporation CDXC	17.9 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	1.68 B	$ 568.91	-2.09 %	$ 43.1 B	USA
Can-Fite BioPharma Ltd. CANF	2.05 M	$ 0.28	-2.28 %	$ 609 M	Israel
Catalyst Biosciences CBIO	20 M	$ 14.62	-4.54 %	$ 962 M	USA
Cerus Corporation CERS	63.6 M	$ 2.19	1.63 %	$ 404 M	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	5.61 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	5.53 B	$ 174.71	1.28 %	$ 25.4 B	USA
BioVie BIVI	2.27 M	$ 1.46	-3.61 %	$ 2.16 M	USA
Celldex Therapeutics CLDX	39.5 M	$ 27.71	-0.82 %	$ 1.78 M	USA
Cortexyme CRTX	9.57 M	-	-1.05 %	$ 67.1 M	USA
Cellectar Biosciences CLRB	25.4 M	$ 3.62	-4.86 %	$ 44.2 M	USA
Deciphera Pharmaceuticals DCPH	100 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	534 M	$ 11.45	0.09 %	$ 741 M	USA
Eloxx Pharmaceuticals ELOX	23.1 M	-	-5.68 %	$ 8.28 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Enochian Biosciences ENOB	29.2 M	-	-	$ 40.5 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA